- Home
- COE vs STXS Comparison
COE vs STXS Comparison
Compare COE & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- STXS
- Stock Information
- Founded
- COE 2011
- STXS 1990
- Country
- COE Singapore
- STXS United States
- Employees
- COE N/A
- STXS N/A
- Industry
- COE Other Consumer Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- COE Real Estate
- STXS Health Care
- Exchange
- COE Nasdaq
- STXS Nasdaq
- Market Cap
- COE 271.9M
- STXS 261.1M
- IPO Year
- COE 2016
- STXS 2004
- Fundamental
- Price
- COE $46.50
- STXS $2.84
- Analyst Decision
- COE
- STXS
- Analyst Count
- COE 0
- STXS 0
- Target Price
- COE N/A
- STXS N/A
- AVG Volume (30 Days)
- COE 18.1K
- STXS 395.6K
- Earning Date
- COE 09-03-2025
- STXS 11-10-2025
- Dividend Yield
- COE N/A
- STXS N/A
- EPS Growth
- COE N/A
- STXS N/A
- EPS
- COE N/A
- STXS N/A
- Revenue
- COE $68,928,000.00
- STXS $31,806,000.00
- Revenue This Year
- COE N/A
- STXS $30.92
- Revenue Next Year
- COE N/A
- STXS $43.27
- P/E Ratio
- COE N/A
- STXS N/A
- Revenue Growth
- COE 93.05
- STXS 33.94
- 52 Week Low
- COE $12.98
- STXS $1.54
- 52 Week High
- COE $51.71
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- COE 69.94
- STXS 55.91
- Support Level
- COE $45.70
- STXS $2.81
- Resistance Level
- COE $48.10
- STXS $2.94
- Average True Range (ATR)
- COE 3.48
- STXS 0.09
- MACD
- COE 0.61
- STXS -0.02
- Stochastic Oscillator
- COE 71.57
- STXS 62.96
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.